Literature DB >> 12187222

A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: urodynamic effects.

Harm H Van Melick1, Ger E P M Van Venrooij, Mardy D Eckhardt, Tom A Boon.   

Abstract

PURPOSE: We compared urodynamic and uroflowmetry improvements in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH) after transurethral prostate resection, contact laser prostatectomy and electrovaporization.
MATERIALS AND METHODS: A prospective randomized controlled trial was performed in men with lower urinary tract symptoms suggestive of BPH who met the criteria of the International Scientific Committee on BPH, had a prostate volume of between 20 and 65 ml., and a Schäfer obstruction grade of 2 or greater. Before and 6 months after treatment urodynamics and free uroflowmetry were performed.
RESULTS: A total of 50, 45 and 46 men were randomized to transurethral prostate resection, laser treatment and electrovaporization, respectively. Baseline characteristics were similar in the 3 groups. Detrusor contractility did not change in any of the treatment groups. The average maximum free flow rate increased by a factor of 2.4 after transurethral prostate resection, 2.5 after laser prostatectomy and 2.4 after electrovaporization. The Schäfer obstruction grade decreased by a factor of 0.3 in all groups. Obstruction (Schäfer grade greater than 2) was not noted after transurethral prostate resection or electrovaporization but it was evident in 2 patients after laser prostatectomy. Effective capacity increased by a factor of 1.5 or more. The incidence of detrusor instability was decreased by half in all groups. The incidence of significant post-void residual urine volume decreased in all groups.
CONCLUSIONS: There were no significant differences in the improvement in urodynamic and uroflowmetry parameters 6 months after treatment when comparing transurethral prostate resection, contact laser prostatectomy and electrovaporization in men with lower urinary tract symptoms suggestive of BPH.

Entities:  

Mesh:

Year:  2002        PMID: 12187222     DOI: 10.1097/01.ju.0000026655.95081.cb

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

2.  Persistent detrusor overactivity after transurethral resection of the prostate.

Authors:  Fadi Housami; Paul Abrams
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

Review 3.  A Review of Laser Treatment for Symptomatic BPH (Benign Prostatic Hyperplasia).

Authors:  Shiva Madhwan Nair; Marie Adrianne Pimentel; Peter John Gilling
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

4.  Efficacy of a vaporization-resection of the prostate median lobe enlargement and vaporization of the prostate lateral lobe for benign prostatic hyperplasia using a 120-W GreenLight high-performance system laser: the effect on storage symptoms.

Authors:  Kang Sup Kim; Sae Woong Choi; Woong Jin Bae; Su Jin Kim; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Tae-Kon Hwang; Sae Woong Kim
Journal:  Lasers Med Sci       Date:  2015-04-02       Impact factor: 3.161

Review 5.  Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptoms.

Authors:  Bilal Chughtai; Vannita Simma-Chiang; Steven A Kaplan
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

6.  Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.